Key facts
- It has raised $18.5M; the latest was Later Stage VC ($18.5M) in Jun 2025.
- Notable investors include Astanor, UC Investments, Magdalena.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Amplifye P24
- ·The full record, as it builds
Funding rounds
No funding rounds for Amplifye P24 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Amplifye P24
Provider of a P24 enzyme intended to unlock the full benefits of protein by enhancing the absorption of critical nutrients. The company's enzyme breaks down protein into small peptides and amino acids, enabling customers to achieve better health benefits such as deeper sleep, sustained energy, muscle recovery, gut health and comfort and mental clarity.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Davis, CA, United States
- Founded
- 2018
- Website
- amplifyeme.com/
- Ownership
- Privately Held (backing)
Amplifye P24 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Amplifye P24 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Amplifye P24 in its N-PORT filings yet. We sweep new filings monthly.